Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
MaxCyte ( (MXCT) ) has provided an announcement.
MaxCyte, Inc., a non-UK issuer, has announced a change in its major holdings, with BlackRock, Inc. acquiring or disposing of voting rights, resulting in a total of 7.65% voting rights held. This notification highlights BlackRock’s significant influence in MaxCyte, potentially impacting the company’s governance and strategic decisions.
More about MaxCyte
YTD Price Performance: -40.43%
Average Trading Volume: 34,071
Technical Sentiment Signal: Buy
Current Market Cap: £204.2M
For an in-depth examination of MXCT stock, go to TipRanks’ Stock Analysis page.